Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BH | Biglari, Sardar | 10% Owner | 30.07.2026 | Verkauf | 16,70 | 273 | 4.559 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 29.07.2026 | Verkauf | 16,71 | 3.305 | 55.227 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 29.07.2026 | Verkauf | 16,71 | 3.306 | 55.243 | Form 4 |
| BHRB | Freeman Danyl R | Chief Human Resources Officer | 29.07.2026 | Steuer-Abgabe | 74,08 | 2.002 | 148.308 | Form 4 |
| BHRB | Freeman Danyl R | Chief Human Resources Officer | 29.07.2026 | Optionsausübung | 43,33 | 2.836 | 122.884 | Form 4 |
| BHRB | Boyle David P | Chair & CEO | 28.07.2026 | Schenkung | — | 1.752 | — | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 17.07.2026 | Verkauf | 16,71 | 11.000 | 183.810 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 17.07.2026 | Steuer-Abgabe | 72,85 | 9.777 | 712.254 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 17.07.2026 | Optionsausübung | 51,58 | 4.110 | 211.994 | Form 4 |
| BHRB | Tissue Robert S | EVP, Financial Strategy | 17.07.2026 | Optionsausübung | 47,47 | 8.599 | 408.195 | Form 4 |
| BHRB | Ritchie Bradford E | EVP, Chief Lending Officer | 16.07.2026 | Steuer-Abgabe | 70,76 | 2.222 | 157.229 | Form 4 |
| BHRB | Ritchie Bradford E | EVP, Chief Lending Officer | 16.07.2026 | Optionsausübung | 51,58 | 2.749 | 141.793 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 16.07.2026 | Verkauf | 16,70 | 2.749 | 45.908 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 15.07.2026 | Verkauf | 16,71 | 6.533 | 109.166 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 14.07.2026 | Verkauf | 16,73 | 1.211 | 20.260 | Form 4 |
| BH | Biglari, Sardar | 10% Owner | 13.07.2026 | Verkauf | 16,74 | 75.000 | 1.255.500 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).